GGMClass II
Control, Hemoglobin
21 CFR 864.8625 / Hematology
GGM is the FDA product code for Control, Hemoglobin, a class II device type, regulated under 21 CFR 864.8625. As of , FDA records hold 15 510(k) clearances under this code, the most recent dated , and 2 recalls.
Classification record
- Product code
- GGM
- Device name
- Control, Hemoglobin
- Regulation
- 21 CFR 864.8625
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 15
- Ingested recalls
- 2
Clearances, product code GGM
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1979 | 1 |
| 1980 | 1 |
| 1985 | 1 |
| 1989 | 1 |
| 1992 | 1 |
| 1996 | 2 |
| 1999 | 1 |
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2019 | 2 |
Applicants with the most clearances
Product code GGM| Applicant | Clearances |
|---|---|
| R & D Systems, Inc. | 3 |
| Bio-Rad | 2 |
| Direct Solutions | 2 |
| Eurotrol B.V. | 2 |
| Bio-Rad Laboratories Inc. | 1 |
| Boehringer Mannheim Corp. | 1 |
| Dade, Baxter Travenol Diagnostics, Inc. | 1 |
| Electrophoresis Corp. | 1 |
| Isolab, Inc. | 1 |
| Quantimetrix Corp. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
